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Capsule summary: 31 
Penicillium marneffei is an AIDS-defining illness. We provide the first identification of 32 
autosomal dominant gain-of-phosphorylation STAT1 mutations causing defective 33 
interferon-gamma and Th17 immunity in patients with penicilliosis, an invasive 34 
mycosis endemic in Southeast Asia.  35 
 36 
 37 
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To the Editor: 39 
Penicillium marneffei (PM) is a pathogenic fungus endemic in Southeast Asia. PM was 40 
an extremely rare pathogen in human before the HIV epidemic, but following the 41 
exponential rise in HIV prevalence in Southeast Asia, penicilliosis emerged as a 42 
clinically significant opportunistic infection and is classified as an AIDS-defining 43 
illness.1 Less commonly, penicilliosis occurs in patients with other immunodeficiencies, 44 
such as severe combined immunodeficiency, common variable immunodeficiency, 45 
hyper-IgM syndrome, hyper-IgE syndrome, the presence of anti-IFNγ autoantibody, 46 
diabetes mellitus, immunosuppressive therapy, and solid organ or hematopoietic stem 47 
cell transplant.1,2 Affected individuals often have disseminated disease with rapid 48 
progression to multi-organ failure and death. 49 
 50 
We previously reported 5 Chinese HIV-negative children and teenagers with 51 
disseminated penicilliosis. Four had co-existing chronic mucocutaneous candidiasis 52 
(CMC) since infancy, and one of them was genetically confirmed to have autosomal 53 
dominant hyper-IgE syndrome (AD-HIES). For the remaining 3 patients, a search for 54 
genetic defects in CARD9, AIRE, STAT3, IL12B, IL12RB1, IFNGR1 was unrevealing.3 55 
The co-existence of CMC and systemic penicilliosis suggested a possible functional 56 
defect of Th17 immune response in these patients. Recently, AD gain-of-function 57 
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missense mutations of STAT1 have been identified in several multiplex kindreds 58 
displaying CMC, autoimmunity and squamous cell carcinoma.4-9 We hypothesized 59 
STAT1 as a candidate gene, and we sought to determine the cellular response to STAT1 60 
activation in these patients. Consent for genetic diagnosis and functional studies was 61 
obtained from parents, and the study was approved by The Institutional Review Board 62 
of The University of Hong Kong / Hospital Authority Hong Kong West Cluster.  63 
 64 
P1, P2 and P3 were 3 unrelated Chinese children, and their clinical presentations and 65 
immunological profile were previously reported in detail.3 The core features and genetic 66 
findings of the patients and their parents are listed in Table 1 and Fig E1 (Online 67 
Repository). Heterozygous missense mutation in STAT1 was identified by Sanger 68 
sequencing in P1 (c.800C>T, p.A267V) and P3 (c.863C>T, p.T288I), and total exome 69 
sequencing in P2 (c.1074G>T, p.L358F; Online Repository). p.A267V is a known 70 
mutation while p.T288I and p.L358F are novel, but missense mutations involving the 71 
same amino acid residues (p.T288A and p.L358W) were reported in patients with 72 
CMC.4-6 Multiple sequence alignment of STAT1 orthologs (HomoloGene, NCBI) 73 
showed that all residues are highly conserved in animals except zebrafish for A267 and 74 
T288, and chicken for L358. 75 
 76 
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Missense mutations affecting the STAT1 coiled-coil domain identified in patients with 77 
AD-CMC have been demonstrated to be gain-of-function mutants with increased 78 
tyrosine-701 residue phosphorylation and enhanced γ-activated sequence (GAS) 79 
promoter binding activity.5 We compared the level of STAT1 phosphorylation in patients 80 
with healthy controls by flow cytometric analysis of intracellular phosphorylated STAT1 81 
(pSTAT1). PBMC from patients and controls were stimulated with recombinant human 82 
IFNα (40,000IU/ml) or IFNγ (5,000 IU/ml) for 20min. Compared with normal controls, 83 
lymphocytes from all patients demonstrated significantly higher percentage of pSTAT1+ 84 
cells and increased phosphorylation intensity in response to IFNα and IFNγ stimulation 85 
(Fig 1 A and B, Fig E2 in the Online Repository). The kinetics of STAT1 86 
dephosphorylation was studied in P1. When treated with tyrosine kinase inhibitor, 87 
almost all STAT1 in control cells was dephosphorylated by 30min; whereas about 50% 88 
and 25% of STAT1 in patient cells remained phosphorylated at 30 and 60min 89 
respectively, indicating prolonged STAT1 phosphorylation in patient cells (Fig 1C). A 90 
missense mutant affecting residue L358 was previously shown to cause delayed 91 
dephosphorylation as well.6  92 
 93 
Next, we determined the proportion of IFNγ and IL17A-expressing T-cells in PMBCs 94 
activated by overnight incubation with PMA (100ng/ml) and ionomycin (1µg/ml) in the 95 
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presence of Brefeldin A. Patients had significantly lower CD3+/IFNγ+ T-cells 96 
(14.8±1.5% vs 43.3±12.8%, p<0.01) and CD3+/IL17A+ T-cells (0.30±0.11% vs 97 
2.15±1.41%, p=0.01; Fig. 1D) compared to normal controls. Finally, we evaluated the 98 
capacity of IFNγ production towards fungal stimulation in P1 and P2. PBMCs were 99 
co-cultured with Candida albicans or PM for 2 days, and supernatants were collected 100 
for IFNγ assay (FlowCytomix, Bender MedSystems). Compared with normal controls, 101 
P1 and P2 produced much lower IFNγ towards both fungi (Fig. 1E). Production of other 102 
cytokines (IL1β, IL6, TNFα and MIP1α) was studied in P1, and was comparable with 103 
normal controls. (Fig E3, Online Repository).  104 
Previous studies demonstrated that patients with CMC caused by 105 
gain-of-phosphorylation STAT1 mutations had impaired Th1 and Th17 response as a 106 
result of defective signaling through the IL12 and IL23 pathways.4-7, 10 Majority of these 107 
gain-of-phosphorylation mutants are located in the coiled-coil domain and two in the 108 
DNA-binding domain.6, 7 Impaired dephosphorylation of STAT1 enhances 109 
gamma-interferon activation factor (GAF)-dependent cellular response to IFNα/β, IFNγ, 110 
and IL27, which are repressors of Th17 development from naïve T-cells. The enhanced 111 
response mediated by STAT1 probably impairs Th17 immunity.5 112 
 113 
The identification of STAT1 and STAT3 mutations in patients with systemic penicilliosis 114 
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suggests the importance of Th1 and Th17 immune response against PM. It is generally 115 
believed that PM establishes diseases in the lungs following inhalation of conidia, and 116 
disseminates in the form of intracellular yeast via the reticuloendothelial system. The 117 
activation of macrophages by IFNγ is essential for their fungicidal activity against PM 118 
through the production of nitric oxide. While PM infection was self-limiting in 119 
wild-type mice, all IFNγ-knockout mice died of systemic mycosis.11 In humans, 120 
individuals with anti-IFNγ autoantibody suffered from disseminated penicilliosis.2 Our 121 
experiments showed that lymphocytes of P1 and P2 exhibited defective IFNγ production 122 
to PM in vitro. To our knowledge, this study shows for the first time that a primary 123 
defect in IFNγ and IL17 immune response may be accountable for human PM infection. 124 
Penicilliosis should be regarded as an indicator of underlying primary 125 
immunodeficiency in HIV-negative individuals after excluding secondary causes. 126 
 127 
It is worth noting that impaired IFNγ and Th17 response in patients with 128 
gain-of-phosphorylation STAT1 mutations can predispose them to invasive mycosis as 129 
well as a range of bacterial and viral infections. Apart from penicilliosis, disseminated 130 
aspergillosis, candidemia, disseminated histoplasmosis and recalcitrant cutaneous 131 
fusariosis were reported.6, 12 P2 and P3 had recurrent sinopulmonary infections caused 132 
by respiratory viruses and encapsulated bacteria, which was also similarly described by 133 
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Uzel et al6 and Takezaki et al.7 Of note, P3 had tuberculous lymphadenitis, recurrent 134 
herpes zoster and EBV-associated hemophagocytosis, supporting previous observation 135 
that AD gain-of-phosphorylation STAT1 mutations are associated with susceptibility to 136 
mycobacterial and herpes virus infections.8 Autoimmunity such as hypothyroidism, 137 
autoimmune hepatitis, systemic lupus erythematosus and type I diabetes mellitus, as 138 
well as malignancy such as esophageal carcinoma can lead to significant morbidities to 139 
this group of patients. The infectious disease susceptibility and phenotypic spectrum of 140 
AD-CMC caused by STAT1 mutations are wider than previously believed, revealing the 141 
divergent roles of STAT1 in host-pathogen interaction, immune tolerance and 142 
carcinogenesis. 143 
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Table 1  Core clinical features of 3 patients with systemic P. marneffei infection and 214 
STAT1 mutations. 215 
 P1 P2 P3 
Gender M F F 
Age of presentation Infancy Infancy infancy 
Family history Nil of significance Nil of significance Nil of significance 
Infections    
  Fungus CMC, disseminated 
PM 
CMC, C. albicans and C. 
tropicalis otitis externa, 
disseminated PM 
CMC, disseminated PM, 
disseminated aspergillosis 
  Bacteria Nil documented Recurrent sinopulmonary 
infections 
Recurrent sinopulmonary 
infections 
  Mycobacteria Nil documented Nil documented M. tuberculosis 
lymphadenopathy 
  Virus Nil documented H1N1 influenza A respiratory 
infection with prolonged carriage, 
CMV pneumonitis 
Recurrent herpes zoster 
reactivation, EBV-associated 
hemophagocytosis 
Mutation    
  Nucleotide change c.800C>t c.1074G>T c.863C>T 
  Amino acid change p.A267V p.L358F p.T288I 
  Domain Coiled-coil domain DNA binding domain Coiled-coil domain 
  Carrier status of 
parents 
Not carrier  
 
Not carrier Mother - not carrier              
(father not checked) 
 216 
 217 
 218 
 219 
 220 
 221 
222 
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Figure legend 223 
Figure 1. Gain-of-phosphorylation STAT1 mutations impaired IFNγ and IL17 responses. 224 
A, PBMCs were stimulated with IFNα or B, IFNγ and analyzed for intracellular 225 
pSTAT1 expression by gating on lymphocytes. The increase in %pSTAT1+ population 226 
in stimulated cells relative to unstimulated cells was calculated. Representative 227 
histograms are shown for P1 and a normal control.  C, PBMCs from P1 were 228 
stimulated by IFNγ followed by treatment with staurosporine for 30 or 60 minutes. The 229 
percentage of intracellular pSTAT1 expression and mean fluorescence intensity (MFI) 230 
were determined in monocytes by flow cytometry. D, PBMCs were stimulated with PMA 231 
plus ionomycin and intracellular expression of IFNγ and IL17A in CD3+ T-cells was 232 
analyzed by flow cytometry. E, PBMCs were co-cultured with C. albicans (MOI of 5) or 233 
P. marneffei conidia (MOI of 1) for 48 hours, and IFNγ in the supernatant was quantified.  234 
